Dana-Farber

With a unanimous approval from @BostonPlans, we’re excited to be taking cancer treatment to a new level by creating New England’s only freestanding inpatient hospital dedicated 100% to cancer in clinical collaboration with Beth Israel Deaconess Medical Center. Learn more about…

Anuj Patel, MD, recently presented research at @myESMO GI, receiving a Best Poster Award for work on a new ctDNA test designed to detect MRD in patients who undergo curative treatment for locally advanced esophageal cancer. The test demonstrated improved detection of MRD. Patel…

Before Benjamin Ebert, MD, PhD, was the CEO, his research redefined blood cancer advancement -- from uncovering RPS14’s role in 5q‑syndrome (2008) to revealing how lenalidomide harnesses the proteasome to degrade “undruggable” transcription factors (2014). Learn about his…

We want YOU on our team! Join @DanaFarber’s team for the Boston Half on Sunday, November 9. Help defy cancer with every mile: jimmyfund.gives/v2c9 💙 #RunDanaFarber

.@KimmieNgMD, director of @DFarberYoungCRC, spoke with @boston25 News today about the rising rates of gastrointestinal cancers, including colorectal, gastric, esophageal and pancreatic cancers, among younger adults. ➡️ bit.ly/3TNc2hz

Gastrointestinal cancers, which include colorectal, stomach and pancreatic cancer, are rising dramatically in younger adults, though doctors aren’t fully sure why. nbcnews.com/health/health-…

GI cancers are now the fastest-growing types of cancer diagnosed in adults younger than 50 in the U.S. @KimmieNgMD co-authored the research review and spoke with @NBCNews about one of the most comprehensive looks at GI cancer trends. @DFarberYoungCRC bit.ly/3GSbdkC

Fewer than 1 in 5 U.S. adults screened for colorectal cancer, despite guidelines. This review in @JAMA_current by @DanaFarber charts a global rise of many GI cancers, noting colorectal cancer leads the alarming trend. @KimmieNgMD @ThejusJay @DFarberYoungCRC…

As powerful as modern cancer medicines are, they don’t work for everyone. What if doctors could quickly test a person’s individual cancer to see which approved treatment would work best? That’s what researchers at Dana-Farber and @MIT are working on. Early results are…

Regular exercise isn’t just great for fitness. It can also reduce cancer risk by managing weight, improving immunity, and lowering inflammation.

We’re proud to be included in @Newsweek’s America’s Greatest Workplaces by State 2025 list. This recognition reflects our ongoing commitment to fostering a supportive, inclusive, and mission-driven workplace – one where every team member has the opportunity to thrive and grow.…

An all-star day with our All-Star friends! @RedSox   Moments like this are made possible thanks to your generous support. Tune in to the @WEEI/@NESN Jimmy Fund Radio-Telethon on August 18 and 19 to watch as we create more unforgettable memories for Dana-Farber patients.…

What happens after cancer treatment ends? @DrVinayakV of @DanaFarber shares what survivorship really means—especially for young adults navigating rare cancers like sarcoma—on the @AllTalkOncology podcast. Full episode here: bit.ly/40i4Iyi

Please join @PTarantinoMD to learn about updates on treatment and research for metastatic breast cancer from the 2025 @ASCO Conference. For more information and to register, please visit bit.ly/4lprw7N.

A new study led by Dipanjan Chowdhury, PhD, co-director of our Center for BRCA and Related Genes, uncovers why some cancers resist PARP inhibitors. The findings could help guide more personalized treatment strategies. Learn more about the study: bit.ly/4ko5CAq

David Pellman, MD, member of Dana-Farber/@BostonChildrens Cancer and Blood Disorders Center, has been elected as a new Associate (foreign) Member of the European Molecular Biology Organization (@EMBO)—a lifelong honor recognizing excellence in the life sciences. He is one of 69…

A new approach called immunopeptidomics is providing researchers with a powerful approach to discovering new ways to train a person’s immune system to fight cancer. Learn more: bit.ly/43HLNPr

A new report from @DanaFarber highlights rising rates of GI cancers in young adults - not just #colorectal, but also #pancreatic, #esophageal, #gastric, #biliary & more. @DFarberYoungCRC @KimmieNgMD @SaraKCharMD @CatherineaOC Read more: bit.ly/40D0kd8

In collaboration with Beth Israel Deaconess Medical Center, our new dedicated cancer hospital, projected to open in 2031, will strengthen Boston’s position as a global leader in oncology — and expand access to the most advanced care for patients across the region. Learn how…

In an in-depth interview with @JAMANetwork, @KimmieNgMD of @DanaFarber discusses highlights from #ASCO25, including research into lifestyle and cancer survival as well as research into the best time of day for treatment. @DFarberYoungCRC Read more here: bit.ly/3ZWNqq8

Marilyn Hammer, PhD, RN, FAAN, director of our Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, was appointed by the @AAN_Nursing to a @theNAMedicine Genomics and Precision Health Roundtable in Washington, D.C. Please join us in congratulating her on…